Periodic Reporting for period 4 - ContraNPM1AML (Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia)

Acute myeloid leukemias (AML) is an aggressive hematological malignancy most commonly affecting elderly population and an unmet medical need. AML with nucleophosmin (NPM1) gene mutations is a new well recognized entity in the World Organization of Health (WHO) classification...